Navigate to Other Sector


Healthcare Newsletter – June 2018

First Prosthetic Iris Approval by US FDA
Biosimilars –Biocon-Mylan’s USFDA approval & Japanese partnerships
Inorganic Growth & Strategic Consolidation in Pharma Contract Services
Perpetuating Momentum in CAR-T cell Therapies
Serum Institute & Sanofi pushing boundaries in infectious disease vaccines with significant technology partnerships
Strategic Partnerships remain Crucial in the booming Health Tech Space

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons